Recent Finacing
Recent Raise
Brenus Pharma develops proteomics-guided allogeneic cancer vaccines on the STC Stimulated-Tumor-Cell platform presenting >200 tumor antigens, standardized and scalable, advancing STC-1010 into first-in-human trials for colorectal and gastrointestinal tumors.
